Sign in

You're signed outSign in or to get full access.

Vininder Singh

Vininder Singh

Chief Executive Officer at BullFrog AI Holdings
CEO
Executive
Board

About Vininder Singh

Founder and CEO of BullFrog AI Holdings since 2017; age 56; Chairman of the Board. Prior experience includes founding and building life sciences companies (Next Healthcare, MaxCyte) and leadership roles at GlobalStem and Thermo Fisher Scientific; education: B.S. Electrical Engineering (Rutgers), M.S. Biomedical Engineering (RPI), MBA (Johns Hopkins) . No proxy disclosure of TSR, revenue or EBITDA performance metrics tied to his tenure; annual bonus metrics are set by the Board but specific KPIs are not disclosed .

Past Roles

OrganizationRoleYearsStrategic impact
Next Healthcare Inc.Founder/Operator— (not disclosed)Personalized diagnostics and adult cell banking venture; startup company-building
MaxCyte, Inc.Founder/Operator— (not disclosed)Cell therapy company; startup company-building
GlobalStem Inc.Executive— (not disclosed)Leadership in life science operations
Thermo Fisher ScientificExecutive, led global cell therapy services— (not disclosed)Built and led cell therapy services business

External Roles

OrganizationRoleYearsNotes
No other public company directorships/disclosures for Singh in 2025 proxy/10‑K .

Board Service & Governance

  • Board roles and independence: Singh serves as Chairman; three independent directors (Elsey, Enright, Hanson). Committees: Audit (Chair: Elsey), Compensation (Chair: Enright), Nominating & Corporate Governance (Chair: Hanson) .
  • Attendance: Board met 5x in FY2024; Audit 5x; Compensation 4x; Nominating 4x; each director attended all meetings of the Board and their committees .
  • Dual-role implications: The Board combines CEO and Chair roles (Singh) and states this is currently in stockholders’ best interests; no Lead Independent Director disclosed .

Fixed Compensation

ItemFY2023FY2024
Base salary$707,666 (included $380,000 current year salary and payment of prior deferred salary) $400,000
Target annual bonusMin 20% of base; max up to 100% (per employment agreement, 2022–2025) Min 20% of base; max up to 100%
Actual annual bonus paid$0 $0

Performance Compensation

  • Equity awards (summary):
    • 2024 grant: Stock options to purchase 79,000 shares total (26,860 exercisable, 52,140 unexercisable as of 12/31/2024), exercise price $3.89, expiration 1/18/2034 .
    • 2024 stock awards (fair value): $230,680 .
    • 2025 refresh equity program: One-time awards with 33% stock (immediate vest) and 67% RSUs vesting 50% on 9/1/2026 and 50% on 9/1/2027; forfeiture restrictions lapse on change in control or a significant financing; aggregate 267,842 shares across all participants if fully vested (individual allocation not disclosed) .
Equity detailGrant/Plan termsVestingSize/PriceExpiration
Stock options2024 CEO grantNot fully specified; 26,860 exercisable, 52,140 unexercisable at 12/31/2024 $3.89 per share 1/18/2034
2025 refresh grant (structure)33% stock (immediate), 67% RSUs; CIC or significant financing accelerates 33% immediate; 67% RSUs: 50% 9/1/2026; 50% 9/1/2027 267,842 shares aggregate across awardees if fully vested (individual not disclosed)

Performance bonus metrics table (company disclosure)

MetricWeightingTargetActualPayoutNotes
Annual bonus KPIsSet by Board per employment agreementNot disclosed$0 paid in 2023–2024Specific KPIs/weightings not disclosed

Change-in-control (CIC) treatment under plan:

  • Company’s 2022 Equity Incentive Plan: upon CIC, outstanding options and SARs become immediately exercisable; RSUs/restricted stock restrictions lapse; performance awards are deemed achieved at 100% of target; Committee may cash-out or cancel underwater options .

Equity Ownership & Alignment

As-of dateCommon shares beneficially owned% of classOptions exercisable within 60 days
Jul 29, 20252,370,376 (2,292,446 common + 77,930 options) 23.33% 77,930
Aug 29, 20252,445,376 (2,367,446 common + 77,930 options) 23.68% 77,930

Alignment safeguards and potential pressure:

  • Hedging and pledging: Company policy prohibits hedging transactions and pledging of company securities; short sales prohibited . Blackout periods and pre‑clearance apply to officers/directors .
  • Ownership guidelines: Not disclosed in proxy/10‑K .
  • Potential selling pressure: 2025 refresh RSUs vest in 2026/2027 and may accelerate on CIC/financing .

Employment Terms

  • Agreement: Employment agreement dated May 16, 2022; base salary $400,000 (biannual reviews); eligible for annual bonus (min 20% target, max 100% based on target achievement); eligible for equity awards .
  • Severance: If terminated without cause, payment of $400,000; no separate CIC cash severance disclosed .
  • Change-in-control equity: Under the equity plan, full vesting acceleration as described above; Committee may cash-out awards .
  • Clawback: Board adopted a clawback policy effective Dec 1, 2023, compliant with Nasdaq Rule 10D‑1, enabling recovery of incentive-based compensation upon material restatement .
  • Indemnification: Company provides director/officer indemnification and expense advancement to fullest extent under Nevada law (see 10‑K Exhibit 10.14) .
  • Non-compete/non-solicit: Not disclosed in filings reviewed .

Director Compensation (context for dual-role)

Director2024 Cash fees2024 Option awards (grant-date FV)Total
Vininder Singh (CEO/Chair)$0$0$0
R. Donald Elsey$45,000$34,050$79,050
William Enright$45,000$34,050$79,050
Jason D. Hanson$45,000$34,050$79,050

Related Party Transactions and Governance Risks

  • Related party transactions: Company states none since Jan 1, 2024 above disclosure thresholds . Historically, a 2021 SAFE with Tivoli Trust (now an ~8% holder) existed ; Tivoli beneficial ownership ~8.15%–8.27% in 2025 tables .
  • Listing/compliance: Nasdaq notice (Aug 21, 2025) for stockholders’ equity below $2.5M; company has 45 days to submit plan and may receive up to 180 days to regain compliance .
  • Capital/dilution levers: Special meeting proposals (Sept 26, 2025) for (i) up to $10M equity line with Lincoln Park (requires potential issuance ≥20% of shares), (ii) reverse split 1:2 to 1:15, (iii) increase shares for the 2022 Equity Plan by 750,000 (pre-split) .

Compensation Structure Analysis

  • Mix and trends: 2024 CEO pay comprised base salary ($400k) and stock awards ($230.7k); no cash bonus—skews toward fixed plus equity vs. variable cash . Year-over-year, cash vs. equity mix shifted toward equity in 2024 with stock awards granted and no bonus paid .
  • Equity design: Options at $3.89 strike (2024) align value with share price appreciation; 2025 refresh awards use time-based RSUs (lower risk vs. options) and immediate stock, signaling near-term retention focus amid underwater options .
  • Performance linkage: Employment agreement references goal-based bonuses, but specific metrics, weights, and results are not disclosed (limits pay‑for‑performance transparency) .
  • Plan governance: No repricing of options without shareholder approval; CIC acceleration to 100% target for performance awards; clawback in place .

Investment Implications

  • Alignment: Singh’s ~24% ownership tightly aligns incentives but concentrates control and reduces float; hedging/pledging prohibitions mitigate misalignment risk .
  • Retention/selling pressure: Time‑based RSUs vesting in 2026/2027 and possible acceleration on financing/CIC could create pockets of supply overhang; blackout/pre‑clearance policies partially manage trading optics .
  • Governance/dilution risk: Active proposals for a reverse split, equity plan increase, and a $10M Lincoln Park facility point to capital needs and potential dilution if executed; Nasdaq equity deficiency adds urgency to financing actions .
  • Pay-for-performance visibility: Lack of disclosed bonus metrics and outcomes reduces transparency; equity remains primary at-risk lever via options and RSUs, with standard CIC acceleration and clawback safeguards .